BCL2 and cancer: However, a potential window for targeting Bcl-2 family members may arise during metastasis of solid tumors [9], where circulating tumor cells or colonizing micrometastatic foci maintain a high level of cancer stemness and are less strongly influenced by the microenvironment, with similarities to hematopoietic malignancies.